American Journal of Cardiology
Volume 105, Issue 3 , Pages 362-367, 1 February 2010

Effect of Intensive Lifestyle Changes on Endothelial Function and on Inflammatory Markers of Atherosclerosis

  • Harvinder S. Dod, MD

      Affiliations

    • Section of Cardiology, Department of Medicine, West Virginia University, Morgantown, West Virginia
    • Corresponding Author InformationCorresponding author: Tel: 304-293-4096; fax: 304-293-7828
  • ,
  • Ravindra Bhardwaj, MBBS

      Affiliations

    • Section of Cardiology, Department of Medicine, West Virginia University, Morgantown, West Virginia
  • ,
  • Venu Sajja, MD

      Affiliations

    • Section of Cardiology, Department of Medicine, West Virginia University, Morgantown, West Virginia
  • ,
  • Gerdi Weidner, PhD

      Affiliations

    • Department of Biology, San Francisco State University, San Francisco, California
    • Preventive Medicine Research Institute, Sausalito, California
  • ,
  • Gerald R. Hobbs, PhD

      Affiliations

    • Department of Community Medicine, West Virginia University, Morgantown, West Virginia
  • ,
  • Gregory W. Konat, PhD

      Affiliations

    • Department of Neurobiology and Anatomy, West Virginia University, Morgantown, West Virginia
  • ,
  • Shanthi Manivannan, MD

      Affiliations

    • Department of Medicine, West Virginia University, Morgantown, West Virginia
  • ,
  • Wissam Gharib, MD

      Affiliations

    • Section of Cardiology, Department of Medicine, West Virginia University, Morgantown, West Virginia
  • ,
  • Bradford E. Warden, MD

      Affiliations

    • Section of Cardiology, Department of Medicine, West Virginia University, Morgantown, West Virginia
  • ,
  • Navin C. Nanda, MD

      Affiliations

    • Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama
  • ,
  • Robert J. Beto, MD

      Affiliations

    • Section of Cardiology, Department of Medicine, West Virginia University, Morgantown, West Virginia
  • ,
  • Dean Ornish, MD

      Affiliations

    • Preventive Medicine Research Institute, Sausalito, California
  • ,
  • Abnash C. Jain, MD

      Affiliations

    • Section of Cardiology, Department of Medicine, West Virginia University, Morgantown, West Virginia

Received 16 July 2009; received in revised form 9 September 2009; accepted 9 September 2009.

Intensive lifestyle changes have been shown to regress atherosclerosis, improve cardiovascular risk profiles, and decrease angina pectoris and cardiac events. We evaluated the influence of the Multisite Cardiac Lifestyle Intervention Program, an ongoing health insurance-covered lifestyle intervention conducted at our site, on endothelial function and inflammatory markers of atherosclerosis in this pilot study. Twenty-seven participants with coronary artery disease (CAD) and/or risk factors for CAD (nonsmokers, 14 men; mean age 56 years) were enrolled in the experimental group and asked to make changes in diet (10% calories from fat, plant based), engage in moderate exercise (3 hours/week), and practice stress management (1 hour/day). Twenty historically (age, gender, CAD, and CAD risk factors) matched participants were enrolled in the control group with usual standard of care. At baseline endothelium-dependent brachial artery flow-mediated dilatation (FMD) was performed in the 2 groups. Serum markers of inflammation, endothelial dysfunction, and angiogenesis were performed only in the experimental group. After 12 weeks, FMD had improved in the experimental group from a baseline of 4.23 ± 0.13 to 4.65 ± 0.15 mm, whereas in the control group it decreased from 4.62 ± 0.16 to 4.48 ± 0.17 mm. Changes were significantly different in favor of the experimental group (p <0.0001). Also, significant decreases occurred in C-reactive protein (from 2.07 ± 0.57 to 1.6 ± 0.43 mg/L, p = 0.03) and interleukin-6 (from 2.52 ± 0.62 to 1.23 ± 0.3 pg/ml, p = 0.02) after 12 weeks. Significant improvement in FMD, C-reactive protein, and interleukin-6 with intensive lifestyle changes in the experimental group suggests ≥1 potential mechanism underlying the clinical benefits seen in previous trials.

 

 This study was supported by West Virginia University Section of Cardiology Foundation Funds, West Virginia University, Morgantown, West Virginia; by Grant W81XWH-06-2-0565 from the Department of the Army, Fort Detrick, Maryland; and Grant MA 155/75-1 from the German Research Foundation (DFG), Bonn, Germany.

PII: S0002-9149(09)02409-6

doi:10.1016/j.amjcard.2009.09.038

American Journal of Cardiology
Volume 105, Issue 3 , Pages 362-367, 1 February 2010